查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1835371

術中影像市場（按模式、組件、應用和最終用戶分類）—2025-2032 年全球預測

Intraoperative Imaging Market by Modality, Component, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，術中成像市場將成長至 70.8 億美元，複合年成長率為 6.97%。

主要市場統計數據
基準年2024年 41.3億美元
預計2025年 44.2億美元
預測年份：2032年 70.8億美元
複合年成長率（%） 6.97%

策略性介紹，闡述推動現代外科護理中採用術中影像的臨床要求、技術推動因素和組織優先事項

術中影像學處於技術創新與臨床需求的交匯點，從根本上改變了外科醫師可視化解剖結構、確認切緣和降低手術風險的方式。影像解析度、即時重建和模態融合技術的進步，將先前僅限於放射科的功能轉移到了手術室，從而實現了更精準、數據主導的干涉。同時，醫療保健服務也發生了變化，包括門診手術中心的興起、縮短時間的壓力以及對經濟高效的手術全期工作流程的需求，這些都加速了基於影像處理的手術路徑的採用和重新設計。

臨床醫生和醫院領導如今要求系統能夠與電子健康記錄無縫整合，提供強大的互通性，並提供檢驗的臨床工作流程，從而顯著改善治療效果。同時，用於影像增強和自動測量的人工智慧等軟體主導功能正在從先導計畫轉向商業產品的組成部分。因此，產品開發的重點集中在模組化硬體平台、擴充性的軟體生態系統以及支援培訓、維護和迭代軟體更新的服務模式。本引言將重點放在影響術中影像投資採購決策和長期策略規劃的臨床需求、技術推動因素和組織促進因素，為後續分析提供組裝。

創新技術和營運轉變正在融合，以創建一個整合的、以軟體為中心的術中成像生態系統，從而最佳化臨床結果和工作流程

術中影像領域正在經歷一場變革性的轉變，這正在重新定義外科團隊規劃、執行和檢驗手術流程的方式。一個關鍵的轉變是各種成像模式向混合平台的融合，這些平台允許在手術過程中同時或依次使用 CT（電腦斷層掃描）、透視、MRI（磁振造影）和高解析度超音波。這種融合支援多平面可視化，並能夠即時決策，從而縮短手術時間並降低再次手術的風險。在硬體融合的同時，軟體主導的創新也正在實現高級視覺化、抗蝕劑和人工智慧輔助讀取，這些共同促成了以精準度和可重複性為中心的全新臨床工作流程。

另一個重大變化涉及手術環境本身。混合手術室和增強型門診手術環境正在成為常態，迫使設備製造商和醫療系統重新考慮其空間佈局、無菌工作流程和培訓計劃。此外，基於價值的報銷和績效指標正促使相關人員優先考慮那些能夠對病患吞吐量、安全性和手術效果產生可衡量影響的解決方案。供應鏈韌性和監管協調正在成為影響供應商選擇和夥伴關係模式的策略考量。總而言之，這些變化標誌著市場正在從孤立的影像處理工具轉向整合的、以軟體為中心的生態系統，旨在為廣泛的專業領域提供一致的臨床效用。

2025 年對進口診斷影像組件徵收的關稅如何鼓勵外科手術提供者進行本地製造、供應鏈多元化和戰略採購

2025年生效的關稅將影響醫療影像組件及相關子系統的進口，並對整個術中影像處理價值鏈產生了一系列營運和戰略影響。關鍵次組件和成像主機的關稅上調導致採購預算緊張，迫使醫療系統和設備製造商重新評估供應商合約和總擁有成本假設。為此，一些製造商加快了本地化進程，實現了供應商多元化，並重新協商了零件採購，以降低進口關稅風險和潛在的前置作業時間波動。

在營運方面，供應鏈經理優先考慮關鍵備件和耗材的庫存緩衝，服務機構則調整維護計劃和備件策略，以應對更長的補貨週期。對於臨床團隊而言，由關稅主導的醫療設備成本凸顯了透過比較有效性數據和程序效率來證明醫療設備效用的重要性。監理機關和採購部門更緊密合作，評估生命週期成本，不僅考慮購置價格，還考慮服務、培訓和軟體更新承諾。總而言之，這些動態有利於擁有強大區域製造地、成熟售後支援和靈活商業性安排的供應商，從而促進了戰略夥伴關係關係，旨在即使在貿易壁壘不斷變化的情況下也能保持對先進影像處理能力的獲取。

深度細分主導的洞察，連接模態選擇、組件生命週期、臨床使用和護理環境，為您的術中成像產品和服務策略提供資訊

細分分析揭示了臨床環境和採購途徑在技術和服務採用方面存在的重要細微差別。就診方式而言，該領域涵蓋電腦斷層掃描、軟性和剛性內視鏡檢查、螢光透視、磁振造影和超音波。每種方式都有不同的基礎設施需求、人員配備影響以及滅菌工作流程，這些因素會影響採購決策和手術室設計。軟性內視鏡平台因其可操作性和手術吞吐量優勢，通常是門診和微創手術的首選，而硬式內視鏡在需要結構剛性和光學性能的專科領域仍然佔據核心地位。

考慮組件級細分突顯了經營模式的差異。設備採購具有資本規劃影響，而服務（分為維護和培訓）代表持續的營運承諾，可在整個生命週期中推動價值。軟體正日益成為一種差異化因素，它提供互通性、影像配準和分析功能，可擴展硬體的臨床效用。應用細分進一步闡明了臨床需求模式。心血管外科、一般外科、神經外科、整形外科和泌尿系統對影像引導的準確性、術中導航和模態選擇都有獨特的需求。門診手術中心優先考慮支援高吞吐量的緊湊、經濟高效的系統，而醫院通常需要多重模式平台和先進的支援服務來滿足複雜的病例組合和監管要求。這種分層細分觀點可幫助相關人員將產品設計、服務產品和商業策略與特定的臨床和操作用例結合。

美洲、歐洲、中東和非洲地區以及亞太地區的採用模式和供應鏈動態將塑造差異化的市場策略和臨床檢驗路徑

區域動態顯著影響術中影像的技術採用、採購偏好和監管格局。在美洲，醫療體系的整合和對價值導向醫療的關注，正在推動對那些展現出高效操作和可衡量臨床效益的系統的投資。該地區的私人和公共採購商通常需要強大的服務網路和全面的培訓計劃，以支援廣泛的臨床部署。相較之下，歐洲、中東和非洲 (EMEA) 地區的政策環境多樣，法律規範和報銷模式也存在顯著差異，這迫使供應商採用針對特定地區的臨床檢驗策略和靈活的商業條款，以在每個醫療保健市場中獲得發展。

在亞太地區，由於產能擴張、政府主導的三級醫療機構投資以及國內製造能力的提升，創新治療方法正在特定市場迅速普及。在每個地區，供應鏈和當地監管部門的核准都會影響產品上市時間和全生命週期支援。這些地理差異凸顯了專業化的上市策略、量身定做的臨床證據以及對本地服務基礎設施的投資的重要性，這些舉措有助於支持術中成像技術的推廣和長期使用。

產品模組化、軟體平台和卓越服務正成為手術影像處理環境中長期採用的決定性競爭因素。

術中成像領域的競爭態勢由硬體創新、軟體生態系統和卓越服務的相互作用所驅動。領先的設備供應商正日益尋求透過模組化設計實現差異化，以實現現場升級和跨模態整合，從而在保護裝置量價值的同時，為先進的影像處理功能創造追加提升銷售機會。軟體供應商正在尋求與硬體製造商和醫療保健系統建立夥伴關係，將分析、配準和影像融合功能直接嵌入到臨床工作流程中，從而將其價值提案從以設備為中心的銷售模式轉變為以平台為中心的經常性收益模式。

提供全面臨床教育、快速維護和結果支援服務的公司往往深深植根於複雜的醫院環境。原始設備製造商 (OEM)、軟體開發人員和臨床中心之間的發展加速了證據生成，並使得快速採用新的術中工作流程成為可能。此外，策略性合作夥伴關係（包括共同開發契約、OEM-供應商整合和有針對性的收購）是確保技術力、區域市場進入和售後市場收益的常用夥伴關係。政府和監管機構仍然是產品引進的關鍵安全隔離網閘，因此臨床檢驗和上市後調查計畫的重要性更高。這些因素共同構成了這樣一種格局：技術創新必須與強大的商業化和支持模式相匹配，才能實現持續的臨床整合。

為技術開發人員和醫療保健系統提供可行的策略建議，以協調產品藍圖、服務模式和採購方法，實現永續的術中影像應用

行業領導者應優先考慮平衡的策略，將技術開發與實際部署和支援結構相結合。首先，加快對支援互通性、雲端分析和模組化升級的軟體平台的投資，確保硬體投資在多個臨床週期內保持價值。制定清晰的API策略，並採用基於標準的互通性，以簡化與電子健康記錄和手術導引套件的整合，減少臨床團隊之間的摩擦。其次，擴大區域製造和分銷能力，以降低貿易政策風險並縮短前置作業時間。

第三，投資專注於特定手術工作流程、能力評估和結果追蹤的綜合服務和臨床培訓項目。第四，尋求有針對性的臨床合作夥伴關係，以產生真實世界證據，證明手術效益、安全性和工作流程效率，這是採購委員會和衛生技術評估夥伴關係日益成長的需求。第五，探索靈活的商業模式，例如訂閱和結果掛鉤定價，以協調供應商和付款人的獎勵。最後，保持嚴謹的併購和夥伴關係策略，專注於收購互補的軟體能力和區域支援資產，而不是重疊的硬體產品組合。這些行動將使您能夠在管理營運和監管複雜性的同時，獲得術中成像的優勢。

採用嚴格的混合方法研究途徑檢驗對術中成像的見解，該方法整合了臨床醫生訪談、供應鏈映射、監管審查和證據三角測量

本執行摘要背後的調查方法將定性一手資料研究與結構化二次分析相結合，以確保研究結果既能反映臨床醫生的經驗，又能反映行業相關訊號。一手資料研究包括對外科醫生、生物醫學工程負責人、採購負責人和臨床營運經理的深入訪談，以掌握關於技術性能、培訓需求和採購重點的第一手觀點。此外，專家圓桌討論會也對這些訪談進行了補充，探討了混合手術室設計、手術方式選擇和上市後支持策略方面的實際挑戰。

二次研究涵蓋同行評審的臨床文獻、監管指南、技術標準和供應商產品文檔，旨在建立客觀的醫療器材能力和臨床用例​​基準。我們進行了供應鏈映射，以確定組件依賴關係和區域製造足跡，案例研究分析展示了成功的實施模式並避免了陷阱。研究結果透過跨資料來源進行三角測量，以檢驗主題並區分孤立觀察結果和系統性趨勢。最後，分析強調了假設的透明度、訪談通訊協定的嚴格記錄以及資訊來源的審核追蹤，以支持報告結論的可重複性和高管層的信心。

總結整合技術、實證部署和靈活的商業化策略將如何決定術中影像實施的成功

術中影像正從一堆分散的工具逐漸發展成為一個緊密結合的臨床整合系統，對手術準確性和患者預後有著顯著的影響。多模態硬體、先進軟體和增強型服務模式的整合，為醫院和門診中心創造了重新思考手術路徑和提升價值交付的機會。同時，貿易政策的轉變、區域監管差異以及報銷優先順序的演變等外部因素正在重塑籌資策略和供應商選擇標準。相關人員，將最有可能從其術中成像投資中獲得最大收益。

展望未來，我們預計重點將轉向能夠透過軟體更新、與臨床系統的無縫互通性以及強大的售後支援實現迭代改進的平台。積極應對供應鏈風險並投資於臨床醫生培訓的組織將減少採用過程中的摩擦，並加速實現臨床和營運效益。最終，最成功的參與企業將是那些將卓越技術與務實、貼近本地市場的商業化策略相結合，以滿足外科團隊和醫療系統管理人員實際需求的企業。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 引入人工智慧驅動的影像導引系統，提高手術準確性並縮短手術時間
  • 將擴增實境平台與術中影像結合，實現跨多個專業的即時解剖視覺化
  • 可攜式照護現場影像設備的出現提高了門診手術中心的可及性
  • 多模態影像技術的進步，結合了超音波-CT、MRI 和螢光成像技術，使得在手術過程中對組織特徵進行全面評估成為可能
  • 開發微創術中影像探頭以改善腫瘤手術過程中的腫瘤邊緣檢測
  • 雲端基礎中影像資料管理解決方案的成長，促進了遠端協作和進階分析
  • 近期監管部門核准的新型螢光成像劑擴大了血管和神經系統可視化的術中應用

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

第8章 術中影像市場（按模式）

  • 電腦斷層掃描
  • 內視鏡檢查
    • 靈活的
    • 死板的
  • 透視
  • 磁振造影
  • 超音波

9. 術中影像市場（按組件）

  • 裝置
  • 服務
    • 維護
    • 訓練
  • 軟體

第 10 章。按應用分類的術中影像市場

  • 心血管系統
  • 一般外科
  • 神經外科
  • 整形外科
  • 泌尿系統

第 11 章。按最終用戶分類的術中影像市場

  • 門診手術中心
  • 醫院

第 12 章。按地區分類的術中影像市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章術中影像市場（按類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 14 章。按國家/地區分類的術中影像市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Siemens Healthineers AG
    • GE Healthcare Holdings, Inc.
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • Medtronic plc
    • Stryker Corporation
    • Shimadzu Corporation
    • Brainlab AG
    • FUJIFILM Holdings Corporation
    • Mindray Medical International Limited
Product Code: MRR-43127F7279EE

The Intraoperative Imaging Market is projected to grow by USD 7.08 billion at a CAGR of 6.97% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.13 billion
Estimated Year [2025] USD 4.42 billion
Forecast Year [2032] USD 7.08 billion
CAGR (%) 6.97%

A strategic introduction that contextualizes clinical imperatives, technological enablers, and organizational priorities driving intraoperative imaging adoption in modern surgical care

Intraoperative imaging sits at the intersection of technology innovation and clinical demand, fundamentally altering how surgeons visualize anatomy, confirm resection margins, and reduce procedural risk. Advances in image resolution, real-time reconstruction, and modality fusion have migrated capabilities previously confined to radiology suites into the operating room, enabling more precise, data-driven interventions. Concurrent shifts in care delivery-such as the rise of ambulatory surgical centers, pressure to shorten procedure times, and the need for cost-effective perioperative workflows-are accelerating adoption and redesign of imaging-enabled surgical pathways.

Clinicians and hospital leaders are now demanding systems that integrate seamlessly with electronic health records, offer robust interoperability, and provide validated clinical workflows that demonstrably improve outcomes. At the same time, software-driven capabilities such as artificial intelligence for image enhancement and automated measurement are transitioning from pilot projects to components of commercial product offerings. As a result, product development priorities emphasize modular hardware platforms, scalable software ecosystems, and service models that support training, maintenance, and iterative software updates. This introduction frames the subsequent analysis by highlighting clinical imperatives, technology enablers, and organizational drivers that collectively shape procurement decisions and long-term strategic planning for intraoperative imaging investments.

Transformative technological and operational shifts are converging to create integrated, software-centric intraoperative imaging ecosystems that optimize clinical outcomes and workflows

The intraoperative imaging landscape is undergoing transformative shifts that redefine how surgical teams plan, execute, and verify procedures. A primary shift is the convergence of modalities into hybrid platforms that allow simultaneous or sequential use of computed tomography, fluoroscopy, magnetic resonance imaging, and high-resolution ultrasound within the operative setting. This convergence supports multi-planar visualization and enables real-time decision-making that can shorten procedures and reduce the likelihood of revision surgeries. Parallel to hardware convergence, software-led innovation is enabling advanced visualization, registration, and AI-assisted interpretation, which together are unlocking new clinical workflows centered on precision and reproducibility.

Another consequential shift concerns the operating environment itself. Hybrid operating rooms and enhanced ambulatory surgical settings are becoming standardized, prompting equipment manufacturers and health systems to rethink footprints, sterility workflows, and training programs. Additionally, value-based reimbursement and performance metrics are encouraging stakeholders to prioritize solutions that demonstrate measurable impacts on patient throughput, safety, and procedural efficacy. Supply chain resilience and regulatory harmonization are emerging as strategic considerations that influence vendor selection and partnership models. These changes collectively indicate a market moving from siloed imaging tools toward integrated, software-centric ecosystems designed for consistent clinical utility across a broad range of specialties.

How 2025 tariff actions on imported imaging components are prompting localized production, diversified supply chains, and strategic procurement adaptations across surgical providers

The tariff measures enacted in 2025 affecting imports of medical imaging components and associated subsystems have introduced a series of operational and strategic implications across the intraoperative imaging value chain. Increased duties on key subassemblies and imaging consoles have placed pressure on procurement budgets, prompting health systems and device manufacturers to reassess supplier contracts and total cost of ownership assumptions. In response, some manufacturers accelerated localization efforts, diversified supplier bases, and renegotiated component sourcing to mitigate exposure to import tariffs and potential lead-time volatility.

Operationally, supply chain managers prioritized inventory buffering for critical spares and consumables, while service organizations adapted maintenance schedules and spare-parts strategies to address longer replenishment cycles. For clinical teams, tariff-driven device cost inflation highlighted the importance of demonstrating device utility through comparative effectiveness data and procedural efficiency gains. Regulatory and procurement functions worked more closely to evaluate lifecycle costs, considering not only acquisition price but also service, training, and software update commitments. Collectively, these dynamics favored vendors with robust regional manufacturing footprints, established aftermarket support, and flexible commercial arrangements, while catalyzing strategic partnerships aimed at preserving access to advanced imaging capabilities despite shifting trade barriers.

Deep segmentation-driven insights connecting modality choices, component lifecycles, clinical applications, and care settings to inform product and service strategies for intraoperative imaging

Segmentation analysis reveals important nuance in how technologies and services are adopted across clinical contexts and procurement pathways. When considering modality, the field spans computed tomography, endoscopy with both flexible and rigid variants, fluoroscopy, magnetic resonance imaging, and ultrasound; each modality brings distinct infrastructure requirements, staffing implications, and sterilization workflows that inform purchasing decisions and OR design. Endoscopy's flexible platforms are often prioritized for ambulatory and minimally invasive procedures due to their maneuverability and procedural throughput advantages, whereas rigid endoscopes remain central to specialties requiring structural rigidity and optics performance.

Examining component-level segmentation highlights divergent business models: equipment investments coexist with recurring service needs and software lifecycles. Equipment purchases carry capital planning implications, while services-divided into maintenance and training-represent ongoing operational commitments that influence total lifecycle value. Software is increasingly the differentiator, providing interoperability, image registration, and analytics capabilities that extend the clinical utility of hardware. Application segmentation further clarifies clinical demand patterns; cardiovascular procedures, general surgery, neurosurgery, orthopedic interventions, and urology each place unique demands on image-guidance precision, intraoperative navigation, and modality selection. Finally, the end-user segmentation captures differences between ambulatory surgical centers and hospitals: ambulatory settings prioritize compact, cost-efficient systems that support high throughput, whereas hospitals typically require multi-modality platforms and advanced support services to meet complex case mixes and regulatory requirements. These layered segmentation perspectives help stakeholders tailor product design, service offerings, and commercial strategies to specific clinical and operational use cases.

Regional adoption patterns and supply chain dynamics shaping differentiated go-to-market strategies and clinical validation pathways across the Americas, EMEA, and Asia-Pacific

Regional dynamics significantly shape technology adoption, procurement preferences, and regulatory interactions across the intraoperative imaging landscape. In the Americas, health system consolidation and a strong emphasis on value-based care are driving investments in systems that demonstrate procedural efficiency and measurable clinical benefits. Private and public purchasers in this region often seek robust service networks and comprehensive training programs to support widespread clinical deployment. In contrast, Europe, Middle East & Africa presents a diverse policy environment where regulatory frameworks and reimbursement models vary widely, prompting vendors to adopt region-specific clinical validation strategies and flexible commercial terms to gain traction across distinct healthcare markets.

Asia-Pacific exhibits rapid uptake of innovative modalities in select markets, supported by capacity expansion, government-led investment in tertiary care centers, and growing domestic manufacturing capabilities. Across regions, supply chain considerations and local regulatory approvals influence time-to-deployment and total lifecycle support commitments. These geographic distinctions underscore the importance of localized go-to-market strategies, tailored clinical evidence generation, and investments in regional service infrastructure to support adoption and long-term utilization of intraoperative imaging technologies.

How product modularity, software platforms, and service excellence are emerging as decisive competitive levers that determine long-term adoption in surgical imaging environments

Competitive dynamics within intraoperative imaging are informed by the interplay of hardware innovation, software ecosystems, and service excellence. Leading equipment providers are increasingly seeking differentiation through modular designs that enable field upgrades and cross-modality integration, thereby protecting installed-base value while creating upsell opportunities for advanced imaging features. Software vendors are pursuing partnerships with hardware manufacturers and healthcare systems to embed analytics, registration, and image-fusion capabilities directly into clinical workflows, shifting the value proposition from device-centric sales to platform-centered, recurring-revenue models.

Service and training excellence are proving to be competitive advantages; companies that offer comprehensive clinical education, responsive maintenance, and outcome-support services tend to achieve deeper penetration in complex hospital environments. Collaboration between OEMs, software developers, and clinical centers accelerates evidence generation, enabling faster adoption of novel intraoperative workflows. Additionally, strategic partnerships-spanning joint development agreements, OEM-supplier consolidation, and targeted acquisitions-are common tactics to secure technological capabilities, regional market access, and aftermarket revenues. Agencies and regulatory bodies remain important gatekeepers for product introductions, increasing the emphasis on clinical validation and post-market surveillance programs. Together, these factors shape a landscape where technical innovation must be matched by robust commercialization and support models to achieve sustained clinical integration.

Actionable strategic recommendations for technology developers and health systems to align product roadmaps, service models, and procurement approaches for sustainable intraoperative imaging adoption

Industry leaders should prioritize a balanced strategy that aligns technology development with pragmatic deployment and support structures. First, accelerate investment in software platforms that enable interoperability, cloud-enabled analytics, and modular upgrades so that hardware investments retain value over multiple clinical cycles. Building a clear API strategy and embracing standards-based interoperability will facilitate integration into electronic health records and surgical navigation suites, reducing friction for clinical teams. Second, expand regional manufacturing and distribution capabilities to mitigate trade-policy risks and shorten lead times; this improves resilience against tariff-driven cost shocks and enhances after-sales responsiveness.

Third, invest in comprehensive service and clinical training programs that emphasize procedure-specific workflows, competency assessments, and outcome tracking; these efforts strengthen clinician confidence and lower barriers to adoption. Fourth, pursue targeted clinical partnerships to generate real-world evidence that demonstrates procedural benefits, safety, and workflow efficiencies-evidence that procurement committees and health technology assessment bodies increasingly require. Fifth, explore flexible commercial models, including subscription and outcome-linked pricing, to align incentives across providers and payers. Finally, maintain a disciplined M&A and partnership strategy focused on acquiring complementary software capabilities and regional support assets rather than duplicative hardware portfolios. Collectively, these actions will position organizations to capture the benefits of intraoperative imaging adoption while managing operational and regulatory complexity.

A rigorous mixed-methods research approach integrating clinician interviews, supply chain mapping, regulatory review, and evidence triangulation to validate intraoperative imaging insights

The research methodology underpinning this executive summary combined qualitative primary research with structured secondary analysis to ensure findings reflect both practitioner experience and contextual industry signals. Primary research included in-depth interviews with surgeons, biomedical engineering leaders, procurement officials, and clinical operations managers to capture first-hand perspectives on technology performance, training needs, and procurement priorities. These interviews were complemented by expert roundtables that explored practical challenges around hybrid operating room design, modality selection, and post-market support strategies.

Secondary research encompassed peer-reviewed clinical literature, regulatory guidance, technical standards, and vendor product documentation to establish an objective baseline for modality capabilities and clinical use cases. Supply chain mapping exercises identified component dependencies and regional manufacturing footprints, while case study analyses illustrated successful implementation patterns and avoided pitfalls. Findings were triangulated across data sources to validate themes and to differentiate one-off observations from systemic trends. Finally, analysis emphasized transparency in assumptions, rigorous documentation of interview protocols, and an audit trail of sources to support reproducibility and executive-level confidence in the report's conclusions.

Concluding synthesis on how integrated technology, evidence-based deployment, and resilient commercialization strategies will determine success in intraoperative imaging adoption

Intraoperative imaging is maturing from a collection of disparate tools into cohesive, clinically integrated systems that materially influence surgical precision and patient outcomes. The convergence of multimodal hardware, sophisticated software, and enhanced service models is creating opportunities for hospitals and ambulatory centers to reimagine procedural pathways and improve value delivery. At the same time, external forces-such as trade policy shifts, regional regulatory variance, and evolving reimbursement priorities-are reshaping procurement strategies and vendor selection criteria. Stakeholders who align technical innovation with durable service infrastructure and robust clinical evidence will be best positioned to realize the full benefits of intraoperative imaging investments.

Looking ahead, the emphasis will continue to shift toward platforms that enable iterative improvement through software updates, seamless interoperability with clinical systems, and strong aftermarket support. Organizations that proactively address supply chain risks and invest in clinician training will reduce friction in adoption and accelerate realization of clinical and operational benefits. Ultimately, the most successful entrants will be those that pair technological excellence with pragmatic, regionally informed commercialization strategies that answer the real-world needs of surgical teams and health system administrators.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of AI-driven image guidance systems for enhancing surgical precision and reducing operation times
  • 5.2. Integration of augmented reality platforms with intraoperative imaging for real-time anatomical visualization across multiple specialties
  • 5.3. Emergence of portable point-of-care intraoperative imaging devices improving accessibility in ambulatory surgical centers
  • 5.4. Advances in multimodal imaging combining ultrasound CT MRI and fluorescence modalities for comprehensive intraoperative tissue characterization
  • 5.5. Development of minimally invasive intraoperative imaging probes for enhanced tumor margin detection during oncologic procedures
  • 5.6. Growth of cloud-based intraoperative imaging data management solutions facilitating remote collaboration and advanced analytics
  • 5.7. Recent regulatory approvals of novel fluorescent imaging agents expanding intraoperative applications in vascular and nerve visualization

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intraoperative Imaging Market, by Modality

  • 8.1. Computed Tomography
  • 8.2. Endoscopy
    • 8.2.1. Flexible
    • 8.2.2. Rigid
  • 8.3. Fluoroscopy
  • 8.4. Magnetic Resonance Imaging
  • 8.5. Ultrasound

9. Intraoperative Imaging Market, by Component

  • 9.1. Equipment
  • 9.2. Service
    • 9.2.1. Maintenance
    • 9.2.2. Training
  • 9.3. Software

10. Intraoperative Imaging Market, by Application

  • 10.1. Cardiovascular
  • 10.2. General Surgery
  • 10.3. Neurosurgery
  • 10.4. Orthopedic
  • 10.5. Urology

11. Intraoperative Imaging Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Intraoperative Imaging Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Intraoperative Imaging Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Intraoperative Imaging Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Siemens Healthineers AG
    • 15.3.2. GE Healthcare Holdings, Inc.
    • 15.3.3. Koninklijke Philips N.V.
    • 15.3.4. Canon Medical Systems Corporation
    • 15.3.5. Medtronic plc
    • 15.3.6. Stryker Corporation
    • 15.3.7. Shimadzu Corporation
    • 15.3.8. Brainlab AG
    • 15.3.9. FUJIFILM Holdings Corporation
    • 15.3.10. Mindray Medical International Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. INTRAOPERATIVE IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. INTRAOPERATIVE IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. INTRAOPERATIVE IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLEXIBLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY RIGID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY MAINTENANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY TRAINING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY UROLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 264. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 265. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 266. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 267. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 268. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 269. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 272. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 273. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 274. GCC INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 303. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 308. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 309. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 310. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 311. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 312. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 313. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. G7 INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 317. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 320. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 321. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 322. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2025-2032 (USD MILLION)
  • TABLE 323. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 324. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 325. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2018-2024 (USD MILLION)
  • TABLE 326. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY SERVICE, 2025-2032 (USD MILLION)
  • TABLE 327. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 330. NATO INTRAOPERATIVE IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 331. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 332. GLOBAL INTRAOPERATIVE IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 333. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 334. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 335. UNITED STATES INTRAOPERATIVE IMAGING MARKET SIZE, BY ENDOSCOPY, 2018-2024 (USD MILLION)
  • TABLE 336. UNITED STATES INT